Literature DB >> 22426141

Prostate stem cell antigen polymorphisms and susceptibility to gastric cancer: a systematic review and meta-analysis.

Tao Wang1, Lina Zhang, Haixin Li, Bangmao Wang, Kexin Chen.   

Abstract

BACKGROUND: Many studies have reported that prostate stem cell antigen (PSCA) polymorphisms (rs2294008 and/or 2976392) are significantly associated with gastric cancer (GC) risk, although the published results are inconsistent. We conducted a systematic review and meta-analysis for relevant literatures to quantitatively evaluate the relationship between PSCA polymorphisms and GC susceptibility.
METHODS: Extensive searches were conducted in three databases up to November 1, 2011. ORs and 95% CIs were used to assess the strength of the associations. The data were further stratified by ethnicity, histopathology, subsite, and study design. All of the associations were evaluated with dominant model and recessive model, respectively. Heterogeneity and publication bias were also assessed by Q test, I(2), and funnel plot accordingly.
RESULTS: Nine articles including 11 case-control data sets were included, with 10,746 GC cases and 9,158 controls for rs2294008 and 6,060 cases and 4,824 controls for rs2976392. The results showed that risk allele carriers were significantly associated with GC risk compared with nonrisk allele homozygotes. In stratification analyses, these associations remained significant for majority of subgroups except for Caucasians and noncardia tumor in dominant model, and cardia tumor in both dominant and recessive model. Random model was used when heterogeneity among studies was detected. No publication bias was observed.
CONCLUSIONS: The two loci of PSCA (rs2294008 and rs2976392) were both significantly associated with GC susceptibility and in linkage disequilibrium. IMPACT: More prospective studies on PSCA polymorphisms at multicenters with sufficient sample size and less heterogeneity will be needed for further validations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426141     DOI: 10.1158/1055-9965.EPI-11-1176

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

Review 1.  Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease.

Authors:  Muhammad Miftahussurur; Yoshio Yamaoka
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-10-16       Impact factor: 3.869

Review 2.  Medical management of gastric cancer: a 2014 update.

Authors:  Elena Elimova; Hironori Shiozaki; Roopma Wadhwa; Kazuki Sudo; Qiongrong Chen; Jeannelyn S Estrella; Mariela A Blum; Brian Badgwell; Prajnan Das; Shumei Song; Jaffer A Ajani
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 3.  Molecular alterations in gastric cancer with special reference to the early-onset subtype.

Authors:  Małgorzata Skierucha; Anya Na Milne; G Johan A Offerhaus; Wojciech P Polkowski; Ryszard Maciejewski; Robert Sitarz
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

4.  An insertion/deletion polymorphism within the proximal promoter of EGLN2 is associated with susceptibility for gastric cancer in the Chinese population.

Authors:  Jian Wang; Jinkun Zhang; Chunxiao Zhou; Lei Chen; Qiang Yu
Journal:  Genet Test Mol Biomarkers       Date:  2014-02-11

Review 5.  Gastric cancer-molecular and clinical dimensions.

Authors:  Roopma Wadhwa; Shumei Song; Ju-Seog Lee; Yixin Yao; Qingyi Wei; Jaffer A Ajani
Journal:  Nat Rev Clin Oncol       Date:  2013-09-24       Impact factor: 66.675

6.  LncPSCA in the 8q24.3 risk locus drives gastric cancer through destabilizing DDX5.

Authors:  Yan Zheng; Tianshui Lei; Guangfu Jin; Haiyang Guo; Nasha Zhang; Jie Chai; Mengyu Xie; Yeyang Xu; Tianpei Wang; Jiandong Liu; Yue Shen; Yemei Song; Bowen Wang; Jinming Yu; Ming Yang
Journal:  EMBO Rep       Date:  2021-09-02       Impact factor: 8.807

7.  PSCA rs2294008 Polymorphism with Increased Risk of Cancer.

Authors:  Peiliang Geng; Jianjun Li; Ning Wang; Juanjuan Ou; Ganfeng Xie; Chen Liu; Xiaoxin Zhao; Lisha Xiang; Yunmei Liao; Houjie Liang
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

8.  PSCA s2294008 C>T and rs2976392 G>A polymorphisms contribute to cancer susceptibility: evidence from published studies.

Authors:  Yong Gu; Qiang-Sheng Dai; Rui-Xi Hua; Bing Zhang; Jin-Hong Zhu; Jian-Wen Huang; Bin-Hui Xie; Shi-Qiu Xiong; Guo-Sheng Tan; He-Ping Li
Journal:  Genes Cancer       Date:  2015-05

9.  PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk.

Authors:  Meng Wang; Xi-Jing Wang; Yun-Feng Ma; Xiao-Bin Ma; Zhi-Ming Dai; Ye Lv; Shuai Lin; Xing-Han Liu; Peng-Tao Yang; Zhi-Jun Dai
Journal:  Ther Clin Risk Manag       Date:  2015-02-13       Impact factor: 2.423

10.  Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.

Authors:  Indu Kohaar; Patricia Porter-Gill; Petra Lenz; Yi-Ping Fu; Adam Mumy; Wei Tang; Andrea B Apolo; Nathaniel Rothman; Dalsu Baris; Alan R Schned; Kris Ylaya; Molly Schwenn; Alison Johnson; Michael Jones; Masatoshi Kida; Debra T Silverman; Stephen M Hewitt; Lee E Moore; Ludmila Prokunina-Olsson
Journal:  J Natl Cancer Inst       Date:  2012-12-23       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.